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Abstract
Background: Urinary incontinence affects approximately 5% (800.000) of the Dutch population. Guidelines recommend
pelvic floor muscle/bladder training for most patients. Unfortunately, general practitioners use this training only
incidentally, but prescribe incontinence pads. Over 50% of patients get such pads, costing €160 million each year. Due
to ageing of the population a further increase of expenses is expected. Several national reports recommend to involve
nurse specialists to support general practitioners and improve patient care. The main objective of our study is to
investigate the effectiveness and cost-effectiveness of involving nurse specialists in primary care for urinary incontinence.
This paper describes the study protocol.
Methods/Design: In a pragmatic prospective multi centre two-armed randomized controlled trial in the Netherlands
the availability and involvement for the general practitioners of a nurse specialist will be compared with usual care. All
consecutive patients consulting their general practitioner within 1 year for urinary incontinence and patients already
diagnosed with urinary incontinence are eligible. Included patients will be followed for 12 months.
Primary outcome is severity of urinary incontinence (measured with the International Consultation on Incontinence
Questionnaire Short Form (ICIQ-UI SF)). Based on ICIQ-UI SF outcome data the number of patients needed to include
is 350. For the economic evaluation quality of life and costs will be measured alongside the clinical trial. For the longer
term extrapolation of the economic evaluation a Markov modelling approach will be used.
Discussion/Conclusion: This is, to our knowledge, the first trial on care for patients with urinary incontinence in
primary care that includes a full economic evaluation and cost-effectiveness modelling exercise from the societal
perspective. If this intervention proves to be effective and cost-effective, implementation of this intervention is
considered and anticipated.
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Background
Problem definition
The disease
Approximately 5% (800.000 people) of the Dutch popu-
lation suffer from urinary incontinence (UI) [1]. This con-
cerns predominantly women, and prevalence increases
with age [2]. Among patients aged over 75, the prevalence
rises up to 30%. UI is infamous for its impact on general
well being and social activities [3,4]. If not treated, UI is a
chronic, not self-limiting disorder with a strong tendency
to worsen over time. It is one of the most important rea-
sons for institutionalisation of elderly people in nursing
homes.
The health care problem
In the Netherlands, annually €160 million is spent on
incontinence pads [1]. Considering the ageing of the pop-
ulation a further increase in these expenditures is expected
[5-7]. Guidelines indicate that for most patients with UI
pelvic floor muscle and/or bladder training is the best
non-invasive treatment to solve the problem, rather than
just compensate the urine loss [2,5,6,8,9]. To date, despite
guidelines, training is used only incidentally by general
practitioners (GPs), probably because it is too time con-
suming [5,6,8,10-12]. Most GPs choose an easier, but
non-curative and ultimately far more expensive, alterna-
tive: prescribing incontinence pads. More than 50% of
patients get incontinence pads, especially the elderly
[1,12].
Usual care
For the vast majority of health problems in the Dutch
population, the GP is the initial person to contact and is
also the gatekeeper for specialist care. This also applies for
UI. Most patients (± 96%) with UI are kept within primary
care [9,13]. Only few patients (total < 5%) are referred to
a specialist (in most cases a urologist or gynaecologist) or
a physical therapist [5,13]. National guidelines on UI are
available for primary care [9,14]. These guidelines are fol-
lowed only incidentally, irrespective of the type of guide-
line or clinical problem involved [10-12,15]. A major
reason why the guidelines are not used, may be because
consultations take more time when following guidelines
[5,16].
Motivation and relevance for the chosen intervention
In recent years, there is a growing emphasis in the Nether-
lands to involve nurse specialists in general practice with
positive findings for chronic disorders [5,6,17,18]. Nurse
specialists have specific expertise, and are capable of
spending more time on motivating patients. Incorporat-
ing nurse specialists may offer a solution to the inade-
quate care for UI with inappropriate prescribing of
incontinence pads. After special training, and using their
specific expertise on UI, they are well equipped to support
the GP after the initial problem definition by the GP.
Their acceptance by patients and GPs, feasibility and use-
fulness in management, and effectiveness in treating UI
have been reported [8,19-23]. However, to our knowl-
edge, studies with a full economic analysis and cost-effec-
tiveness modelling exercise from the societal perspective
of involving nurse specialists for UI are not available.
Objective
The main objective is to study whether the availability and
involvement of a nurse specialist in a new role as a substi-
tute for the GP in the management of UI in general prac-
tice leads to more efficient care for adult UI patients. We
envision that the effects of the intervention will be such
that care will improve, hence more patients can be treated
effectively and therefore will use less incontinence pads,
which leads to a reduction in costs.
The following research questions were formulated:
1. Does the availability and the involvement of a nurse
specialist as a substitute for the GP for adult persons with
UI lead to a reduction in the severity of UI compared to
care as usual by the GP?
2. Does the involvement of such a nurse specialist lead to
a better quality of life of the patients?
3. Is the involvement of such a nurse specialist cost-effec-
tive compared to care as usual by the GP?
4: Does the involvement of a nurse specialist on UI lead to
a better satisfaction of patients, GPs and other health care
providers?
5. To what extent do GPs use the nurse specialist?
6. What are reasons for the GPs for (not) using the nurse
specialist? Does the availability of the nurse specialist
change the perception of GPs about the treatment via the
nurse specialist?
Methods/Design
This pragmatic prospective multi-centre two-armed rand-
omized controlled trial is now conducted among patients
with UI in general practices in four regions in the Nether-
lands. Initially, the trial was planned to be conducted in at
least two regions (Maastricht and Nijmegen). During the
preparation of the trial expert key persons on UI in the
regions of Helmond and The Hague expressed their will-
ingness to participate as well (see Figure 1). The study pro-
tocol is approved by the Medical Ethical Committees of all
the involved medical centres and hospitals. Patients will
be randomized into an experimental group with availabil-
ity of care by the nurse specialist or a control group receiv-BMC Health Services Research 2008, 8:84 http://www.biomedcentral.com/1472-6963/8/84
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Study design Figure 1
Study design. * Primary outcome measure: • severity urinary incontinence (ICIQ-UI SF) # Secundary outcome meas-
ures: 1. health care and productivity, time, travel costs. 2. generic QOL: EuroQol. 3. incontinence specific QOL: IIQ-7. 4. 
quantification of symptoms: bladder diary. 5. satisfaction of patients. 6. perceptions GPs and nurse specialists. $ needed number 
with and without drop-out/loss-to-follow up
Control
N=210 (175)
Usual care 
GP
Maastricht- Nijmegen
The Hague- Helmond
Adults with UI consulting GP or known by GPs 
Randomization
patients
N=420 (350)$
Intervention
N=210 (175)
Nurse specialist
Inclusion criteria:
•SUI, UUI, mixed
•Well versed in Dutch
•Informed consent
Exclusion criteria:
•Specific pathology
•Severe cognitive problems
•Not motivated
Baseline
Outcome 
Measures*#1 - 5
6 months
Outcome 
Measures*#1, 2
3 months
Outcome 
Measures*#1 - 6
12 months
Outcome 
Measures*# all
Cost- effectiveness 
analysis.
Time horizon: 
duration of 
lifespan of patients
9 months
Outcome 
Measures*#1, 2
Allocation
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ing the usual care from their GP. Included patients will be
followed for 12 months.
The randomization process is concealed from those
responsible for recruiting patients using central telephone
randomization. Because only a small number of patients
is to be expected per GP, patients are randomized using a
separate randomization list for each participating region.
Blinding patients and health care providers is not possi-
ble. Personnel collecting outcome data are blinded to the
patients treatment allocation. A patient in the control
group can not be referred by the GP to use the route via
the nurse specialist, to avoid contamination.
Study population
Inclusion criteria
All consecutive patients consulting their GP for symptoms
and signs of stress, urgency and mixed UI (according to
the guidelines of the Dutch College of General Practition-
ers on UI [9]) for a period of one year and UI patients
diagnosed as such by the GPs in the past are eligible for
the study [9,24,25]. Patients who consult their GP for UI
are actively recruited by the GP to participate in the study.
Known UI patients are selected by the GP on eligibility
and will be invited by the GP to participate in the study.
In case of doubt by the GP on eligibility the patient will be
invited for a consultation on UI by the GP. Regularly and
repeatedly, GPs will be stimulated to include patients for
the study. Information, reminders and newsletters are part
of the strategy to enhance the GPs awareness of the avail-
ability of the nurse specialist and its potential benefits for
this specific health care.
Exclusion criteria
Excluded are patients below 18, women with prolapse
degree III or more, patients with signs of reflex- or over-
flow incontinence, tumours in the abdomen, severe neu-
rological diseases associated with incontinence (multiple
sclerosis, CVA, diabetes, cauda equina syndrome), actual
urinary tract infection, hematuria without urinary tract
infection, men below 65 with unexplained incontinence,
patients with failure after operation or failure of conserv-
ative therapy during the past half year (or longer, provided
there is no relapse which causes dissatisfaction with the
present situation), severe cognitive problems, not well
versed in Dutch, refusing to participate/cooperate,
patients for whom the GP considers the management via
the nurse specialist as impossible/undesired and UI
patients in care and nursing homes.
Informed consent
After written informed consent all patients included have
baseline data collection, urologic, obstetric and gynaeco-
logic history in women and urologic history in men. All
measurements in this study are performed by postal ques-
tionnaires managed by an independent research-assistant.
Intervention(s)
The intervention is designed as close as possible to treat-
ment options in clinical practice, including 'cascades' of
patient management choices (Figure 2). When the patient
is allocated to the intervention group the GP refers the
patient to the nurse specialist according to a care protocol.
All participating GPs are personally informed about the
demarcation and definition of job responsibilities and
competence profile of the nurse specialist towards GPs
and other health care professionals involved [26,27]. This
information is also available to the GP as written informa-
tion.
Training and competences of the nurse specialist [see 
Additional file 1]
The training program for the nurse specialists how to sup-
port the GP, by taking care of the diagnostic and therapeu-
tic management of patients with the most prevalent types
of UI, is gradually developed during the preparation
period of the study. All nurse specialists will have to prove
their competences in an individual assessment.
Intervention nurse specialist [see Additional files 2 and 3]
The main goal of the intervention of the nurse specialist is
to provide a tailored, patient specific diagnostic and treat-
ment plan, thereby preventing or reducing the use of
incontinence pads. Based on guidelines and protocols the
nurse specialist takes over tasks from the GP related to
diagnostics, intervention and monitoring of patients with
the most prevalent types of UI (stress, urgency and mixed
UI) [28-31]. The GP keeps final responsibility. Further-
more, the nurse specialist supports patient motivation,
compliance and adherence both on the short and the long
term by monitoring patients over time in a systematic
way. This ensures that patients will accept, understand, are
willing and able to adhere to advices on lifestyle, bladder-
and pelvic floor muscle training according to a health edu-
cation model [22]. Another task of the nurse specialist is
to give adequate information and advice about (when still
necessary) the choice and the use of non-curative means
like incontinence pads. She/he will always report to the
GP and acts as the contact person between the other
healthcare providers. In case of unclear pathology, a com-
plex health problem or failure of treatment the nurse spe-
cialist can advice a referral to a specialist or specialised
physical therapist. In all cases, the decision for referral is
to be made by the GP. Altogether this means that the
nurse specialist will report to the GP on each patient after
first problem assessment and at the end of the interven-
tion period. A regular meeting between nurse specialist
and GP to discuss patients will be organised when needed.BMC Health Services Research 2008, 8:84 http://www.biomedcentral.com/1472-6963/8/84
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Flow chart intervention nurse specialist for patients with UI Figure 2
Flow chart intervention nurse specialist for patients with UI. PFM (T) = Pelvic Floor Muscle (Training); GP = general 
practitioner; PPT = pelvic physiotherapist; NS = nurse specialist. The used terminology is according to the definitions as rec-
ommended by the International Continence Society.
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Outcome measurements and data collection
The primary outcome measure is the severity of involun-
tary loss of urine. This is measured by the self-completed
condition specific International Consultation on Inconti-
nence Questionnaire Short Form (ICIQ-UI SF) which
measures frequency, volume and impact on daily life of
involuntary urine loss [32,33]. The outcome is a sum
score of the first two weighted items and the Visual Ana-
logue Scale (VAS) score of impact on daily life. The ques-
tionnaire underwent extensive psychometric testing and is
rated by the International Consultation on Incontinence
(ICI) as Grade A, meaning highly recommendable [3].
Secondary outcome measures:
1. Generic quality of life is measured with the self-com-
pleted standardised EuroQol quality of life questionnaire
(EQ-5D) [34]. It provides a simple descriptive profile, a
single index value for health status and a VAS scale (0–
100). Health states defined by the 5-dimensional descrip-
tive system can be converted into a weighted health state
index by applying scores from EQ-5D "value sets" elicited
from general population samples.
2. Health care costs (the use of diagnostics, treatment and
incontinence pads) and non-medical costs (productivity
costs, time costs and travel costs) are collected using both
registration systems and retrospective cost questionnaires.
Because of recent literature and own experiences in similar
trials the use of these questionnaires was favoured above
cost diaries [35-37].
3. Condition-specific quality of life is measured with the
self-completed International Incontinence Questionnaire
(IIQ). For practical reasons we used the short form of this
validated (7 items) questionnaire that measures impact of
urinary loss on five domains: 'mobility', 'physical func-
tioning', 'social functioning', 'emotional health' and
'embarrassment' [38,39].
4. Symptoms relevant for UI (the degree of pad usage,
times of micturition, incontinence episodes, the degree of
urgency, complications, complaints) is measured with a
self-completed bladder diary during 3 consecutive days
[40-43]. Considering the restricted diagnostic value of
lower urinary tract symptoms (LUTS) for a final diagnosis
(grade D) and to minimize complexity and to maximize
compliance (Gordon 2001) [3] to registration of the blad-
der diary this registration will be restricted to a micturition
time chart with the most relevant LUTS which give an
impression of type, severity and impact of UI [3].
5. Patients' satisfaction with provided care for UI by the
GP and/or the nurse specialist was originally planned to
be measured with the for UI adjusted QUOTE self-com-
pleted questionnaire. This showed to be not suitable to
answer our research question. For this reason we devel-
oped a new questionnaire. For the development of the
questionnaire topics relevant to either the route via the
nurse specialist or the usual care of the GP were identified
in interviews with UI patients and experts in the field par-
ticipating in the study. We developed a set of items to ena-
ble us to measure and test multi-items scales. The items
are related to relevant themes with respect to care for UI
patients according to standards on UI.
6. Evaluation of the availability and involvement of the
nurse specialist by GPs will be measured by interviews and
questionnaires after the study in a sample of the partici-
pating GPs. Data will be collected by a trained research
assistant.
7. Evaluation by all participating nurse specialists on role
participation will be measured by a semi-structured inter-
view and questionnaires before, during and after the
study.
Data collection of all outcome measures will be done at 3
and 12 months. For the cost-effectiveness study extra fol-
low-up data collection of the primary outcome measure,
costs and quality of life will take place at 6 and 9 months.
In case of non-response, telephone reminders will take
place two to three weeks after sending the questionnaires.
Adverse events/effects will be monitored for the duration
of the study.
Sample size calculation and feasibility of recruitment
Based on a mean score on the ICIQ-UI SF [44] of 7.18 (sd
6.64), and an expected improvement of 2 on the outcome
scale from 0 to 21 (which gives a delta value of 2/6.64 =
0.301), a power of 80% and a significance level of 0.05,
and given the two-sided H1-hypothesis, that the new pro-
fessional improves the effect, the needed number of
patients per arm is 175 patients. We expect a drop-out rate
during the trial of 20% and therefore we set our target at
(rounded off) 2 times 210 = 420 patients. As shown in
previous Dutch studies on UI, GP practices are able to
include 5–10 patients per year. Therefore, we need 50 to
88 GPs to participate. Recruitment of the needed numbers
of patients seems highly feasible since the power calcula-
tion was based on the regions of Maastricht and Nijmegen
alone (total number of inhabitants: 500.000; total
number of GP practices: approximately 240 GPs).
Data-analysis and presentation/synthesis
Data collection, processing and analyses will be done with
SPSS/PC, version 12 and 15. Variables will be analysed
with the parametric Student-t test or the non-parametric
U-test of Mann-Whitney (Wilcoxon ranksumtest) and the
Wilcoxon-test for two unpaired samples. To compare theBMC Health Services Research 2008, 8:84 http://www.biomedcentral.com/1472-6963/8/84
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effects between different groups repeated measures
AN(C)OVA and linear regression models will be used.
Analyses will be done according to the intention-to-treat-
principal. In case of missing values, non-compliance, loss-
to-follow-up, drop-outs and protocol deviations also per-
protocol analyses will be done for the economic evalua-
tion only. To compare GPs using the nurse specialist and
GPs who do not, per-protocol analyses will be performed.
Economic evaluation
A cost-effectiveness analysis will be performed from the
societal perspective. In this analysis the incremental
health effects and the incremental costs of involving a
nurse specialist in primary care for adult patients with UI,
as compared to usual care, will be weighted. The major
potential health effects of involving a nurse specialist are
likely to result from an increase in the utilization of avail-
able therapies with proven effectiveness for UI, such as
bladder training and/or pelvic floor muscle training. The
EuroQol will be used to calculate quality adjusted life
years (QALYs) following the algorithm developed by
Dolan et al. [45]. Health care costs, productivity costs and
patient and family costs will be included in the analysis.
Health care costs (the use of diagnostics, treatment and
incontinence pads) and productivity costs, time costs and
travel costs will be collected using both registration sys-
tems and retrospective cost questionnaires. The cost ques-
tionnaire will be filled in by the patients at baseline, 3, 6,
9 and 12 months. Cost calculation will be based on real
prices or on unit prices from the Dutch Guideline for Cost
Calculation [46]. For the nurse specialist a cost price cal-
culation will be performed. Costs associated with produc-
tivity loss will be calculated using the friction costs
method [46]. In case of household, or other unpaid activ-
ities, shadow prices will be used. When clinical relevant
effects of decreasing the impact of UI on daily life, and
thus the use of incontinence pads, will be found during
the one year of the study, a Markov type health state tran-
sition model will be used to calculate the long-term cost-
effectiveness of the intervention [see Additional file 4].
Discussion
In this paper we describe the study protocol of, to our
knowledge, the first randomized controlled trial on care
for UI patients in general practice that includes a full eco-
nomic evaluation and cost-effectiveness modelling exer-
cise from the societal perspective.
Next to this, despite the growing emphasis in the Nether-
lands on involving nurse specialists in general practice,
specifically for UI this is still unfamiliar and the delega-
tion of tasks to a nurse specialist can be considered as a
new approach [17,47].
(Potential) strengths of the study protocol
- The study design
The choice for a pragmatic design ensures that the inter-
vention is as close as possible to treatment options in clin-
ical practice (including 'cascades' of patient management
choices). This makes implementation in the future easier.
A care protocol with the preferred route via the nurse spe-
cialist is used. GPs will be well informed and stimulated
to follow this care protocol. Despite this, there is a chance
that GPs will not optimally use the nurse specialist
because of perceptions of GPs or unfamiliarity with this
new professional. For this reason perceptions such as will-
ingness to use the nurse specialist, expectations, first expe-
riences and reasons/promoting or hampering factors for
GPs to use or not to use this route will be measured and
actively monitored.
- Recruitment strategy
A particular strength is the recruitment strategy. Both new
and already diagnosed UI patients are eligible. By recruit-
ing already diagnosed UI patients we are likely to also
include the majority of UI patients who mainly use pads
and did not receive adequate conservative treatment
before. In addition, this approach will be helpful to
include the required number of patients in the available
time period.
- Randomization approach
A third strength of our study protocol is the randomiza-
tion approach, in which allocation is concealed and done
by an external independent person. Randomization is
done on patient level. An alternative would be that GPs
would be randomized instead of patients. As GPs in the
control group probably will have difficulties to include
enough patients, this alternative seemed unfavourable.
- Competences of the nurse specialists
Another strength of our study protocol is that all nurses
are trained and assessed in a uniform way to assure that
the intervention will be carried out conform the interven-
tion protocol in all four regions. To be able to get insight
into their actual performance, all nurses will register their
actions during all patient visits. This registration will be
used to search for factors related to the intervention proc-
ess that might influence the effectiveness of the interven-
tion. It may also show an individual learning curve, as this
intervention is new for the nurses.
- Outcome measurements
Diagnosing the type of UI is primarily done by the GP.
Since we really want to mimic routine practice as close as
possible we did not choose for objective measurements to
confirm the diagnose of the type of UI by urodynamic
testing. Neither did we choose for a pad test to measure
the severity of UI. On the one hand because we felt that aBMC Health Services Research 2008, 8:84 http://www.biomedcentral.com/1472-6963/8/84
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pad test would be too much of a burden especially for the
control group only receiving usual care. On the other
hand because a pad test may act as a feedback which
might influence the usual care too much. Furthermore, in
the analyses by taking the baseline scores into account the
information bias resulting from subjective self-reports
will be reduced. Moreover, the self-reported data on
healthcare use and costs will be validated by data from
external sources like insurance companies (patients will
give their informed consent).
(Potential) limitations of the study protocol
- Participant selection
Selection of participants may limit generalization of the
results of this study as selective non-response of patients
as well as selective drop-out and selective refusal of GPs
are possible.
Selective refusal of patients to participate might be
assumed as some patients label UI as an accepted aspect
of normal aging or do not experience adverse conse-
quences. Possibly, such UI patients will refuse more often
to participate than other UI patients. The same might be
assumed about the more complex UI patients, who are
severely burdened by multi-morbidity, and might be
afraid to become even more burdened with participating
in the study measurements. To limit such selective refusal
patients living in care – and nursing homes are excluded
from the study. To prevent selective drop out of patients
in poor health states, the questionnaires are designed to
minimize completion burden. Selective refusal of GPs to
participate is anticipated from GPs already working with
(in)continence nurses or specialised physical therapists.
Randomization on patient level could lead to contamina-
tion, and bias the results of this study. However, the influ-
ence of contamination is minimised, because patients in
the usual care group have no access to the intervention of
the nurse specialist. Nevertheless, it is possible that partic-
ipating GPs are encouraged by the study to give more
attention to the UI patients participating in the usual care
group. As a result our findings may be conservative.
Conclusion
The study will provide evidence whether the availability of
a nurse specialist in a new role as substitute for the general
practitioner leads to more effective and efficient care for
adult urinary incontinence patients. Furthermore, the
results will show whether this availability improves the
quality of life of patients and the satisfaction of patients,
general practitioners and other care providers. If this inter-
vention proves to be effective, implementation of this
intervention is considered and anticipated.
First results of this study will become available autumn
2008.
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